Showing 1 - 7 results of 7 for search 'Ze-Jiang Zhan', query time: 0.04s Refine Results
  1. 1
    New frontiers in proton therapy: applications in cancers

    New frontiers in proton therapy: applications in cancers by Tai-Ze Yuan, Ze-Jiang Zhan, Chao-Nan Qian

    Published 2019-10-01
    Get full text
    Article
  2. 2
    Case Report: Neoadjuvant and Adjuvant Crizotinib Targeted Therapy in Stage IIIA-N2 ALK-Positive Non-Small-Cell Lung Cancer

    Case Report: Neoadjuvant and Adjuvant Crizotinib Targeted Therapy in Stage IIIA-N2 ALK-Positive Non-Small-Cell Lung Cancer by Xiao-Hong Xie, Xiao-Hong Xie, Ze-Jiang Zhan, Ze-Jiang Zhan, Yin-Yin Qin, Yin-Yin Qin, Ju-Hong Jiang, Ju-Hong Jiang, Wei-Qiang Yin, Wei-Qiang Yin, Rong-Hui Zheng, Rong-Hui Zheng, Shi-Yue Li, Shi-Yue Li, Cheng-Zhi Zhou, Cheng-Zhi Zhou

    Published 2021-03-01
    Get full text
    Article
  3. 3
    Incidence, consequences, and predictors of serious chemotherapy‐induced thrombocytopenia in nasopharyngeal carcinoma

    Incidence, consequences, and predictors of serious chemotherapy‐induced thrombocytopenia in nasopharyngeal carcinoma by Lu‐Lu Zhang, Xi Chen, Ying‐Ying Huang, Chi‐Xiong Liang, Meng‐Yun Qiang, Zhuo‐Chen Cai, Ze‐Jiang Zhan, Ying Deng, Jia‐Yu Zhou, Hao‐Yang Huang, Xiang Guo, Xing Lv

    Published 2023-07-01
    Get full text
    Article
  4. 4
    Tumor residue in patients with stage II–IVA nasopharyngeal carcinoma who received intensity-modulated radiation therapy: development and validation of a prediction nomogram integrating postradiotherapy plasma Epstein–Barr virus deoxyribonucleic acid, clinical stage, and radiotherapy dose

    Tumor residue in patients with stage II–IVA nasopharyngeal carcinoma who received intensity-modulated radiation therapy: development and validation of a prediction nomogram integra... by Ying-Ying Huang, Jia-Yu Zhou, Ze-Jiang Zhan, Liang-Ru Ke, Wei-Xiong Xia, Xun Cao, Zhuo-Chen Cai, Ying Deng, Xi Chen, Lu-Lu Zhang, Hao-Yang Huang, Xiang Guo, Xing Lv

    Published 2023-05-01
    Get full text
    Article
  5. 5
    Toripalimab plus capecitabine in the treatment of patients with residual nasopharyngeal carcinoma: a single-arm phase 2 trial

    Toripalimab plus capecitabine in the treatment of patients with residual nasopharyngeal carcinoma: a single-arm phase 2 trial by Xun Cao, Hao-Yang Huang, Chi-Xiong Liang, Zhuo-Chen Lin, Jia-Yu Zhou, Xi Chen, Ying-Ying Huang, Ze-Jiang Zhan, Liang-Ru Ke, Lu-Jun Han, Wei-Xiong Xia, Lin-Quan Tang, Shan-Shan Guo, Hu Liang, Xiang Guo, Xing Lv

    Published 2024-01-01
    Get full text
    Article
  6. 6
    Widely targeted quantitative lipidomics and prognostic model reveal plasma lipid predictors for nasopharyngeal carcinoma

    Widely targeted quantitative lipidomics and prognostic model reveal plasma lipid predictors for nasopharyngeal carcinoma by Xi Chen, Ying-xue Li, Xun Cao, Meng-yun Qiang, Chi-xiong Liang, Liang-ru Ke, Zhuo-chen Cai, Ying-ying Huang, Ze-jiang Zhan, Jia-yu Zhou, Ying Deng, Lu-lu Zhang, Hao-yang Huang, Xiang Li, Jing Mei, Guo-tong Xie, Xiang Guo, Xing Lv

    Published 2023-06-01
    Get full text
    Article
  7. 7
    A deep learning-based semiautomated workflow for triaging follow-up MR scans in treated nasopharyngeal carcinoma

    A deep learning-based semiautomated workflow for triaging follow-up MR scans in treated nasopharyngeal carcinoma by Ying-Ying Huang, Yi-Shu Deng, Yang Liu, Meng-Yun Qiang, Wen-Ze Qiu, Wei-Xiong Xia, Bing-Zhong Jing, Chen-Yang Feng, Hao-Hua Chen, Xun Cao, Jia-Yu Zhou, Hao-Yang Huang, Ze-Jiang Zhan, Ying Deng, Lin-Quan Tang, Hai-Qiang Mai, Ying Sun, Chuan-Miao Xie, Xiang Guo, Liang-Ru Ke, Xing Lv, Chao-Feng Li

    Published 2023-12-01
    Get full text
    Article

Search Tools: